EUVIMED · CrossrefZeitschrift
Seminars in Cancer Biology
ISSN 1044-579X · Elsevier BV
Neueste Artikel
DNA methylation in human disease: From biological mechanisms to clinical applications
3D Bioprinting as an In Vitro Tool to Model the Tumor Microenvironment
Recent advances in unlocking T cell signatures in cancer through deep learning
Hidden architecture of resistance: The extracellular matrix in melanoma’s immune landscape
Role of oral microbiome in cancer immunotherapy
Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications
Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction
Obesity, type 2 diabetes and cancers of the digestive system
Energy metabolism, nutrition and cancer
Microbiota and cancer immunotherapy: Mechanisms, clinical implications, and precision therapeutics
Leveraging cancer metabolism to translate into effective therapeutics
Protein lactylation in cancer and other pathologies: Epigenetic regulation of glycolysis and its therapeutic perspectives
Obesity and GEP-NEN: what’s new?
Beyond cardiovascular health: The pharmacotherapeutic potential of statins in oncology
Microbial metabolites for cancer immunotherapy: Current evidence and future directions
From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer
Microbiota metabolism and immune regulation: From mechanisms to immunotherapeutic applications in cancer
Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
Extracellular vesicles and the lipid messengers: The adipose tissue connection to cancer and metabolic disease.
Clonal evolution and therapy resistance in the era of precision cancer medicine: evolutionary trajectories in pediatric cancer
Host-microbiota interactions in genitourinary cancer immunotherapy
Insulin resistance in cancer risk and prognosis
The microbiome-immune cell interaction network: Advancing tumor immunotherapy
From awareness to action: Revolutionizing cardio-oncology in China
Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy
Reopening Pandora’s box: Is there a role for HDL in breast cancer?
The impact of sarcopenic obesity on cancer clinical outcomes
Obesity-driven inflammation and cancer risk: A comprehensive review
The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury
Jahrgänge
2027 · 12026 · 512025 · 1222024 · 532023 · 1062022 · 3982021 · 2122020 · 1702019 · 1102018 · 1242017 · 932016 · 472015 · 912014 · 642013 · 732012 · 642011 · 572010 · 612009 · 622008 · 612007 · 582006 · 522005 · 562004 · 622003 · 612002 · 582001 · 522000 · 491999 · 481998 · 271997 · 251996 · 471995 · 49
EUVIMED